CYH Stock Recent News
CYH LATEST HEADLINES
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today the consideration payable in respect of the previously announced cash tender offer (the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase any and all of the Issuer's outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”), on the terms and subject to the conditions set forth in the Offer to Purchase, dated July 28,.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today the early tender results of the previously announced cash tender offer (the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase any and all of the Issuer's outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”), on the terms and subject to the conditions set forth in the Offer to Purchase, dated July 28, 2025, as ame.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (”CHS”) (NYSE: CYH) released its 2025 Community Impact Report today. In addition to spotlighting the Company's actions to deliver quality healthcare, strengthen its workforce, and provide vital economic benefit for the communities it serves, this year's report also celebrates the Company's 40th anniversary. Community Health Systems began in 1985 as a company solely focused on small rural hospitals and has since evo.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), has increased the principal amount of the Issuer's approximately $1,757 million aggregate principal amount outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”) that it can repurchase under its previously announced cash tender offer (the “Tender Offer”) from $1,470 million to $1,757 million.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), has priced an offering of $1,790 million aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Notes”) (the “Notes Offering”). The size of the offering was increased by $290 million aggregate principal amount of Notes subsequent to the initial announcement of the proposed offering.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), has commenced a cash tender offer (the “Tender Offer”) for up to $1,470 million of the Issuer's approximately $1,757 million aggregate principal amount outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”), on the terms and subject to the conditions set forth in the Issuer's Offer to Purcha.
Community Health Systems, Inc. Announces Offering of $1,500 Million of Senior Secured Notes Due 2034
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), intends to offer $1,500 million aggregate principal amount of Senior Secured Notes due 2034 (the “Notes”), subject to market and other conditions (the “Notes Offering”). The Issuer intends to use the net proceeds of the Notes Offering, together with cash on hand, to refinance a portion of its outstanding.
Community Health Systems, Inc. (NYSE:CYH ) Q2 2025 Earnings Conference Call July 24, 2025 11:00 AM ET Company Participants Anton Hie - Corporate Participant Kevin J. Hammons - President & CFO Tim L.
Community Health Systems: Stock Tanks On Q2 Earnings, CEO Retires - I Sense A Contrarian Opportunity
Community Health Systems' sharp post-earnings sell-off reflects deep investor concerns over high leverage, regulatory headwinds, and management uncertainty. Despite guidance for >$12bn annual revenues and positive adjusted EBITDA, heavy debt ($10.8bn) and ongoing net losses weigh on valuation and bankruptcy risk. Asset sales and positive cash flow offer time and flexibility, with no major debt repayments due until 2027, supporting a potential turnaround thesis.
CYH posts Q2 loss despite revenue beat, as patient days and adjusted admissions decline year over year.